Semaglutide for Medical Weight Loss

What Is Semaglutide?

Semaglutide is a medication in a class called GLP-1 receptor agonists — it mimics a naturally occurring hormone (glucagon-like peptide-1) that the body releases after eating. It was first developed to help manage type 2 diabetes and is also used, under different branding and dosing, for chronic weight management. TrimDoc providers may prescribe compounded or brand-name semaglutide depending on what is clinically appropriate and available for your specific prescription.

How Does It Work?

GLP-1 receptor agonists work through several mechanisms that a provider will discuss with you in more detail: they can slow how quickly the stomach empties, increase feelings of fullness after eating, and act on appetite-regulating areas of the brain. In people with type 2 diabetes, GLP-1 medications also help the body regulate blood sugar. The combined effect, for weight management, is generally a reduction in appetite and calorie intake — but individual response varies, and semaglutide is intended to be used alongside, not instead of, guidance on nutrition and activity from your care team.

Who Might Be a Candidate?

Whether semaglutide is appropriate for you is a clinical decision, made by a licensed provider during your consultation — not something determined by a self-assessment or online quiz. In general, providers evaluating candidates for GLP-1 therapy consider factors such as body mass index, weight-related health conditions, prior weight-management history, and overall health status. Your TrimDoc provider will review your specific history before making any recommendation. See Who May Be Eligible for GLP-1 Therapy for a full breakdown of what providers generally consider.

Who Should Avoid It

Semaglutide and other GLP-1 receptor agonists are not recommended for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — this is a well-established contraindication for this medication class. Your provider will also ask about pregnancy or plans for pregnancy, breastfeeding, a history of pancreatitis, severe gastrointestinal disease, and other medications you take, since these can affect whether semaglutide is appropriate for you. Always disclose your full health history during your evaluation, even if you are unsure whether something is relevant.

What the Consultation Process Involves

1. Book an appointment. Choose an available telehealth time through Vagaro — no payment is required to see availability.
2. Complete your evaluation. Meet with a licensed provider by video. They review your health history, current medications, and goals.
3. Receive a clinical determination. Your provider decides whether semaglutide, a different treatment, or no medication is the appropriate next step — this decision happens after your evaluation, not before it.
4. Ongoing follow-up if prescribed. If semaglutide is prescribed, your care continues with monitoring and follow-up visits to review your response and any side effects.

Lifestyle Expectations

Providers typically recommend that GLP-1 therapy be paired with attention to nutrition, physical activity, and other health habits — medication is generally considered one part of a broader weight management plan, not a stand-alone solution. Your care team can discuss what that looks like for your specific situation during and after your consultation.

Possible Side Effects

The most commonly reported side effects of semaglutide involve the digestive system: nausea, vomiting, diarrhea, constipation, decreased appetite, and injection-site reactions. These are often more noticeable when starting treatment or after a dose increase, and your provider may adjust your plan to help manage them. Side effects vary by individual, and this list is not exhaustive — discuss any symptom you experience with your care team. See the full GLP-1 Side Effects guide for more detail, including how side effects are monitored.

Serious Risks

Less common but serious risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder problems (including gallstones), and kidney problems (often related to dehydration from significant gastrointestinal side effects). In animal studies, semaglutide and similar medications caused thyroid C-cell tumors; it is not known whether this occurs in humans, which is why semaglutide is not recommended for anyone with a personal or family history of MTC or MEN2 (see “Who Should Avoid It” above). Seek prompt medical attention for severe abdominal pain, signs of a serious allergic reaction, or any symptom that concerns you.

Safety Monitoring

Ongoing care with a GLP-1 medication typically includes periodic follow-up visits so your provider can monitor how you're responding, review any side effects, and adjust your plan as needed. Regular communication with your care team — not just the initial consultation — is part of using this medication safely.

Storage

GLP-1 injectable medications generally require specific storage conditions (commonly refrigeration, with some formulations allowing limited room-temperature storage before use). Because storage instructions can differ between compounded and brand-name formulations, always follow the specific instructions provided with your prescription by your pharmacy, and ask your TrimDoc care team if anything is unclear.

Missed Doses

If you miss a dose of semaglutide, contact your TrimDoc care team or follow the instructions provided with your specific prescription. Do not double up on doses or make changes to your schedule without guidance, since the right course of action can depend on how much time has passed and your individual prescription.

Long-Term Treatment

Weight management with GLP-1 medications is generally approached as an ongoing, medically supervised process rather than a short course of treatment. How long treatment continues is an individual decision made between you and your provider, based on your response, tolerability, and health goals over time.

Stopping Therapy

Talk to your provider before stopping semaglutide. As with other weight-management medications, changes in weight and appetite can occur after stopping treatment, and your care team can help you plan for that transition rather than navigating it on your own.